in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
FDA accepts Sanofi's new diabetes drug application
11:41 PM MDT | July 7, 2014 | Natasha Alperowicz
Sanofi (Paris) said today that the US FDA has accepted for review the company’s new drug application for Toujeo, an investigational basal insulin. This follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicine Agency for EU countries on 27 May 2014. “By reaching this key milestone in the approval process, we are pleased to take another step forward with Toujeo, an investigational new based insulin that has been evaluated in a broad range of people living with diabetes,” said Pierre Chancel, senior...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee